# Valdepharm - Inspection Records

Source: https://www.keypedia.com/companies/valdepharm/9a1bab54-2984-4dec-8384-e3aaa423bda7

> Inspection records and compliance data for Valdepharm in Val De Reuil Cedex, None. Access full analysis and detailed observations.

---

## Details

- Name: Valdepharm
- FEI Number: 3000538143
- City: Val De Reuil Cedex
- State: None
- Country Name: France
- Address Line 1: Parc Industriel D Incarville, Voie De L Institut
- Zip Code: None
- Business Operations: API MANUFACTURE, FDF MANUFACTURE

## Related Documents

- [FDA Inspection 1181516 - Valdepharm - 2022-01-21](https://www.keypedia.com/records/fda_inspections/valdepharm/98fa0921-e3ae-4122-8843-0071adc9637d) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 21, 2022
- [EIR - Valdepharm - 2015-04-27](https://www.keypedia.com/records/eir/valdepharm/9a36ab0d-fc04-4d75-845a-18908513ead1) — source: FDA, date: April 27, 2015
- [483 - Valdepharm - 2015-04-27](https://www.keypedia.com/records/483/valdepharm/6e5a71ab-207b-44c7-a4a3-babf547f5333) — source: FDA, date: April 27, 2015
- [FDA Inspection 923783 - Valdepharm - 2015-04-27](https://www.keypedia.com/records/fda_inspections/valdepharm/3cf5a26e-09f8-4f22-a9ce-819f776d0db5) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 27, 2015
- [FDA Inspection 923783 - Valdepharm - 2015-04-27](https://www.keypedia.com/records/fda_inspections/valdepharm/501e7267-cdf4-4880-b310-2cdf5fe864ce) — classification: Voluntary Action Indicated (VAI), source: FDA, date: April 27, 2015
- [FDA Inspection 891979 - Valdepharm - 2014-07-10](https://www.keypedia.com/records/fda_inspections/valdepharm/992ba72d-73ad-4f49-add8-e0c36777b182) — classification: No Action Indicated (NAI), source: FDA, date: July 10, 2014
- [FDA Inspection 788262 - Valdepharm - 2012-05-25](https://www.keypedia.com/records/fda_inspections/valdepharm/4d032987-be41-430e-b9e9-63b67de73e63) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 25, 2012

## Related Companies

- [GlaxoSmithKline Manufacturing S.p.A.](https://www.keypedia.com/companies/glaxosmithkline-manufacturing-spa/11f7427f-c02e-4b80-91dd-f90cbe9b90a9)
- [Merck Teknika LLC](https://www.keypedia.com/companies/merck-teknika-llc/64024257-325c-45de-a5c2-70cbe8abecf5)
- [GlaxoSmithKline, LLC.](https://www.keypedia.com/companies/glaxosmithkline-llc/7ab59069-93ea-4898-a74a-874992c27286)
- [Shandong New Time Pharmaceutical Co. Ltd.](https://www.keypedia.com/companies/shandong-new-time-pharmaceutical-co-ltd/470fe860-121a-4594-b9a5-e6bf05ce1926)
- [Hainan Shuangcheng Pharmaceuticals Co Ltd](https://www.keypedia.com/companies/hainan-shuangcheng-pharmaceuticals-co-ltd/920c7235-0cdd-4c0a-884c-43e1f605c1c6)
- [ONY Biotech, Inc.](https://www.keypedia.com/companies/ony-biotech-inc/a2997e30-1b39-4dea-9fec-a960aafcefd0)
- [CareFusion 213, LLC](https://www.keypedia.com/companies/carefusion-213-llc/a1fedbce-120c-4b06-8def-c5a653db579a)
- [Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Huanghe Road Site)](https://www.keypedia.com/companies/jiangsu-hengrui-pharmaceuticals-co-ltd-huanghe-road-site/02eeb237-fdd8-40a0-b45c-d4d88f49eb6c)
- [Latina Pharma S.p.A.](https://www.keypedia.com/companies/latina-pharma-spa/9cb7e758-39a0-4b4c-bfad-93d1468f5d38)
- [ENDO Pharmaceuticals Solutions, Inc.](https://www.keypedia.com/companies/endo-pharmaceuticals-solutions-inc/73c5da1a-04ad-4b56-9fae-f0a1371df51f)

## Related Officers

- [Senior Consumer Safety Officer ](https://www.keypedia.com/people/marcus-f-yambot/a2266014-ae7e-4d64-aeba-a8cfb873f100)
- [company_representative](https://www.keypedia.com/people/julien-joelle/01f4e01f-d4a8-416c-960d-e1afde7f170f)
- [company_representative](https://www.keypedia.com/people/olivier-champion/32e11cf8-6d5e-421a-a103-8267db4fc3d4)